Takeda Pharmaceuticals International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Takeda Pharmaceuticals International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Takeda Pharmaceuticals International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Takeda Pharmaceuticals International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
56 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Takeda Pharmaceuticals International AG (Takeda), a subsidiary of Takeda Pharmaceutical Company Limited is a pharmaceutical company that offers researches, development, manufacturing and marketing of pharmaceutical products. The company offers treatments in respiratory and immunology, central nervous system, cardiovascular and metabolic, cancer, general medicine, and vaccines areas. It also provides services such as contract manufacturing and product development, product packaging and quality control services. Takeda offers portfolio of innovative, patented products, branded generics and over-the-counter products.

Takeda Pharmaceuticals International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on maj

  
Source:
Document ID
GDPH17857D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201682
Takeda Pharmaceuticals International AG, Medical Devices Deals, 2010 to YTD 2016101
Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016113
Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare, Deal Details1439
  Partnerships141
    Takeda Pharma International Terminates Co-Promotion Agreement With Merck For Daxas141
    Nycomed Enters Into Co-Marketing Agreement With Orion For Easyhaler152
    Nycomed Enters Into Co-Marketing Agreement With Almirall171
    Nycomed Enters Into Distribution Agreement With Almirall, Anika, Bionorica, CSL And Helsinn182
    Mitsubishi Tanabe Pharma Terminates Its Co-Development Agreement With Nycomed International201
    Essen BioScience Enters Into Collaboration Agreement With Nycomed211
    Nycomed International Management Enters Into Distribution Agreement With Vifor Pharma For Intravenous Iron Products221
    Nycomed Enters Into Co-Promotion Agreement With Merck232
    Nycomed Enters Into Co-Marketing Agreement With Merck252
    Ayanda Enters Into Distribution Agreement With Nycomed For CONCORDIX271
  Licensing Agreements281
    Valeant Canada Enters into Licensing Agreement with Takeda Pharma for Edarbi and Edarbyclor282
    Apricus Biosciences Enters Into Licensing Agreement With Takeda Pharma For Vitaros302
    Nycomed International Terminates Licensing Agreement With DURECT For POSIDUR322
    Nycomed Enters Into Licensing Agreement With Almirall For Ebastine341
    Nycomed Enters Into Licensing Agreement With Norgine For MOVIPREP352
    Nycomed Enters Into Licensing Agreement With Orion For Easyhaler372
    Nycomed Enters Into Licensing Agreement With F. Hoffmann-La Roche For Bonviva392
    DURECT Amends Licensing Agreement With Nycomed412
    Eurand Enters Into Licensing Agreement With Nycomed For ZENPEP432
    DURECT Amends Development And License Agreement With Nycomed451
  Acquisition461
    Takeda Pharma Completes Acquisition Of Nycomed International For US$13,681 Million464
    Nycomed Completes Acquisition Of Laboratorios Farmacol501
    Nycomed Acquires 51.34% Stake In Guangdong Techpool Bio-Pharma512
Takeda Pharmaceuticals International AG - Key Competitors531
Key Employees541
Locations And Subsidiaries551
  Head Office551
Appendix561
  Methodology561
  About GlobalData561
  Contact Us561
  Disclaimer561

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Takeda Pharmaceuticals International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Takeda-Pharmaceuticals-International-AG-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-18382>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Takeda Pharmaceuticals International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Takeda-Pharmaceuticals-International-AG-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-18382>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research